申请人:Japan Tobacco Inc.
公开号:EP1669345A1
公开(公告)日:2006-06-14
A therapeutic agent for hyperlipidemia which has no side effects on the liver unlike conventional MTP inhibitors and has excellent MTP inhibitory activity. Also, provided is an ester compound represented by the general formula (1):
or a pharmaceutically acceptable salt thereof.
一种治疗高脂血症的药物,它与传统的 MTP 抑制剂不同,对肝脏没有副作用,并且具有优异的 MTP 抑制活性。此外,还提供了一种由通式(1)代表的酯类化合物:
或其药学上可接受的盐。